New Division Director for Digital Health and Director for the Digital Health Center of Excellence
This newly created position is within the Office of Strategic Partnerships and Technology Innovation in the FDA's Center for Devices and Radiological Health (CDRH).
FDA has named Troy Tazbaz as its new Division Director for Digital Health and Director for the Digital Health Center of Excellence. Most recently, Tazbaz was the Senior Vice President, Industry Business Unit for Oracle. In his new role, Tazbas will prepare the agency to partner with innovators and create regulatory guidance for the application of artificial intelligence within the convergence of healthcare IT and medical devices.
Troy Tazbaz
This newly created position is within the Office of Strategic Partnerships and Technology Innovation in the FDA's Center for Devices and Radiological Health (CDRH). As such, Tazbaz will partner with a broad range of national and global government agencies, institutions, academia, and various organizations representing patients, consumers, and healthcare professionals. Tazbaz will be responsible for building the FDA's key resources for establishing digital health guidelines and efficient regulatory pathways for the integration of digital and cloud-based technologies.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
